A double-blind crossover qualification phase (hydromorphone 8 mg vs. placebo) was followed by a washout period and then randomization to a 5-period, 10-sequence crossoverReduced cognitive and psychomotor impairment with extended-release oxymorphone versus controlled-release oxycodone....